Executive Committee: Medpace Holdings, Inc.

Manager
Positions heldSince
August Troendle

August Troendle

67 year

Chief Executive Officer 1992-06-30
Founder 1992-06-30
Jesse Geiger

Jesse Geiger

49 year

President 2021-07-31
Stephen Ewald

Stephen Ewald

54 year

Compliance Officer -
General Counsel 2012-05-31
Corporate Secretary 2012-05-31
Susan Burwig

Susan Burwig

61 year

Chief Operating Officer 2015-05-31
Daniel O’Leary

Daniel O’Leary

Chief Tech/Sci/R&D Officer -
Todd Meyers

Todd Meyers

Sales & Marketing 2013-07-31
Lauren Morris

Lauren Morris

Investor Relations Contact -
Kevin Brady

Kevin Brady

49 year

Director of Finance/CFO 2021-07-31
Treasurer 2019-01-31
Brandon Ebken

Brandon Ebken

Chief Tech/Sci/R&D Officer 2021-09-30
Reinilde Heyrman

Reinilde Heyrman

63 year

Chief Tech/Sci/R&D Officer 2017-08-31

Composition of the Board of Directors: Medpace Holdings, Inc.

Director
CommitteesSince
August Troendle

August Troendle

67 year

Chairman 1992-06-30
Fred Davenport

Fred Davenport

72 year

Audit Committee 2018-08-12
Governance Committee 2018-08-12
Nominating Committee 2018-08-12
Compensation Committee Chair 2018-08-12
Robert Kraft

Robert Kraft

53 year

Audit Committee 2016-06-30
Compensation Committee 2016-06-30
Governance Committee
Nominating Committee
Cornelius McCarthy

Cornelius McCarthy

64 year

Compensation Committee 2018-08-12
Governance Committee
Nominating Committee
Brian Carley

Brian Carley

70 year

Governance Committee
Nominating Committee
Audit Committee Chair 2016-06-30
Femida Gwadry-Sridhar

Femida Gwadry-Sridhar

62 year

Governance Committee 2023-01-15
Nominating Committee 2023-01-15

Former Officers and Directors: Medpace Holdings, Inc.

Insider
Positions held
SinceUntil
Ashley Keating
Ashley Keating
Director/Board Member 2019-05-16 2024-06-29
Independent Dir/Board Member 2019-05-16 2024-06-29
Thomas C. King
Thomas C. King
Director/Board Member 2019-10-23 2022-12-30
Independent Dir/Board Member 2019-10-23 2022-12-30
Yun Le
Yun Le
Chief Tech/Sci/R&D Officer - 2021-09-30
Corporate Officer/Principal - -
Steven Johnson
Steven Johnson
Chief Tech/Sci/R&D Officer - 2020-08-31
General Counsel 2014-07-31 -
Bruce Brown
Bruce Brown
Director/Board Member 2016-10-26 -
Independent Dir/Board Member 2016-10-26 -
Supraj Ram Rajagopalan
Supraj Ram Rajagopalan
Director/Board Member 2014-01-31 2018-08-30
Independent Dir/Board Member 2014-01-31 2018-08-30
Anastasya Molodykh McFarlane
Anastasya Molodykh McFarlane
Director/Board Member 2017-06-14 2018-08-09
Independent Dir/Board Member 2017-06-14 2018-08-09
John Richardson
John Richardson
Director/Board Member 2017-06-14 2018-08-09
Independent Dir/Board Member 2017-06-14 2018-08-09
Alexander Leslie
Alexander Leslie
Director/Board Member 2014-01-31 2017-06-14
Independent Dir/Board Member 2014-01-31 2017-06-14
Matthew Norton
Matthew Norton
Director/Board Member 2015-09-30 2017-06-14
Independent Dir/Board Member 2015-09-30 2017-06-14
Kurt Arthur Brykman
Kurt Arthur Brykman
Director/Board Member - 2015-07-13
Penelope J. Bucknell
Penelope J. Bucknell
Human Resources Officer 2012-01-31 -
Mary Kuramoto
Mary Kuramoto
Public Communications Contact - -
Caitilin Hamill
Caitilin Hamill
General Counsel - -

Age distribution of managers

Parity Men Women

Male 13
Female 3

Of which Executive Committee

Male 8
Female 2

Of which Directors

Male 6
Female 0
ESG Refinitiv
C+

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a global provider of clinical research-based drug and medical device development services. The Company is focused on providing scientifically driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. Its drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Its operations are based in North America, Europe, and Asia.
Employees
5,800
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW